Case report highlights the importance of genetic testing in redefining epilepsy syndromes.
To describe a case of a 19-year-old patient initially diagnosed with Lennox–Gastaut syndrome during childhood, later found to harbor a pathogenic SHANK3 mutation, highlighting the evolving role of genetic testing in redefining epilepsy syndromes once attributed to idiopathic or developmental etiologies.
No takes yet. Share an insight, caveat, or question.
Tola et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: